154 results on '"Alperi, Mercedes"'
Search Results
2. Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study
3. A Composite Indicator to Assess the Quality of Care in the Management of Patients With Rheumatoid Arthritis in Outpatient Rheumatology Clinics
4. Indicador compuesto para evaluar la calidad asistencial en el manejo de los pacientes con artritis reumatoide en las consultas externas de Reumatología
5. Managing psoriatic arthritis in different clinical scenarios
6. L’âge à l’apparition du rhumatisme psoriasique pourrait faciliter la caractérisation de son phénotype
7. Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?
8. Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis
9. Quality Standards for Rheumatology Outpatient Clinic. The EXTRELLA Project
10. Estándares de calidad asistencial para las consultas externas de reumatología. El proyecto EXTRELLA
11. Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
12. Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
13. Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab
14. La stratification par âge d’apparition de la maladie avec limite fixée à 30 ans : une méthode efficace pour identifier le psoriasis associé à PSORS1 chez les patients atteints de rhumatisme psoriasique
15. Adverse effects of bisphosphonates
16. Efectos adversos de los bisfosfonatos
17. Stratification by age of onset with 30 years as age limit is an effective means of identifying PSORS1-associated psoriasis in patients with psoriatic arthritis
18. The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis
19. Psoriasis and psoriasiform lesions induced by TNFα antagonists: the experience of a tertiary care hospital from northern Spain
20. Sexual disinterest among spondyloarthritis patients. Comparison between psoriatic arthritis and axial spondyloarthritis using a sexuality-specific question from the ASAS Health Index
21. Additional file 1 of Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
22. HLA-B*08 identified as the most associated MHC locus for anti-carbamylated protein antibody-positive/anti-CCP-negative rheumatoid arthritis
23. Entheseal ultrasound abnormalities in patients with SAPHO syndrome
24. Interactions Between Rheumatoid Arthritis Antibodies Are Associated With the Response to Anti-tumor Necrosis Factor Therapy
25. ASAS Health Index as an Addition to Routine Clinical Practice
26. Dropped Head Syndrome in a Patient With Scleromyositis
27. Performance of the ASAS Health Index for the Evaluation of Spondyloarthritis in Daily Practice
28. Enfermedad de Pyle: un modelo humano de homeostasis corticotrabecular diferenciada
29. Pyle's disease: A human model of differentiated cortical and trabecular homeostasis
30. Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study
31. Determinants of psoriatic arthritis in patients with psoriasis
32. The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis.
33. HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis.
34. High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?
35. Paniculitis mesentérica en un paciente con espondilitis anquilosante
36. Mesenteric Panniculitis in a Patient With Ankylosing Spondylitis
37. Clinical Differences between Men and Women with Psoriatic Arthritis: Relevance of the Analysis of Genes and Polymorphisms in the Major Histocompatibility Complex Region and of the Age at Onset of Psoriasis
38. Psoriasis and psoriasiform lesions induced by TNFα antagonists: the experience of a tertiary care hospital from northern Spain
39. HLA-DR17 est associé à une enthésite dans le rhumatisme psoriasique
40. La stratification par âge d’apparition de la maladie avec limite fixée à 30ans : une méthode efficace pour identifier le psoriasis associé à PSORS1 chez les patients atteints de rhumatisme psoriasique
41. HLA-DR17 is associated with enthesitis in psoriatic arthritis
42. L’expression clinique, contrairement aux paramètres évolutifs, peut varier selon l’âge de début de la maladie dans le rhumatisme psoriasique
43. Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis
44. Effectiveness of a clinical practice intervention in early rheumatoid arthritis.
45. An Unexpectedly High Frequency of MEFV Mutations in Patients With Anti-Citrullinated Protein Antibody-Negative Palindromic Rheumatism.
46. RS3PE Syndrome: Bad or Good Prognosis?
47. HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis
48. Disease Activity in Psoriatic Arthritis Index and Psoriatic Arthritis Impact of Disease Questionnaire: correlation and sensitivity to change in a real clinical setting.
49. Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab.
50. Could the clinical differences between men and women with psoriatic arthritis be explained in part by genetic factors?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.